Revolution Medicines, Inc. Strong execution of two ongoing Phase 3 trials of daraxonrasib; company expects to substantially complete enrollment of RASolute 302 in patients with pancreatic cancer this year New non-small cell lung cancer clinical data from RAS(ON) inhibitor portfolio support strategies for first-line …
Net Investment Income of $0.41 Per Share for Q1 2025; Declared Quarterly Distribution of $0.41 Per Share; Stable NAV/Strong Credit Quality NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC) (the “Company”, “SLRC”, “we”, “us”, or “our”) today reported net …
BETHESDA, Md., May 7, 2025 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) announced today that its Board of Directors has declared a cash dividend of $0.12 per share of common stock for May 2025. The dividend is payable on June 10, 2025 to common …
BEDFORD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that management will participate in the Sidoti Virtual Investor Conference on …
SUNNYVALE, Calif., May 07, 2025--(BUSINESS WIRE)--Alpha and Omega Semiconductor Limited ("AOS") (NASDAQ: AOSL) today reported financial results for the fiscal third quarter of 2025 ended March 31, 2025. The results for the fiscal third quarter of 2025 ended March 31, 2025 were as follows: …
SCOTTSDALE, Ariz., May 7, 2025 /PRNewswire/ --TASER's Axon brand includes a growing suite of connected products and services from body cameras and digital evidence management tools to mobiles apps. Software & Services revenue grows 39% to $263 million Annual recurring revenue grows 34% to …
DENVER, May 07, 2025--(BUSINESS WIRE)--CSG (NASDAQ: CSGS) today reported results for the quarter ended March 31, 2025. Raising 2025 Non-GAAP Profitability and EPS Guidance Targets; Reiterating All Others Strong Cash Flow from Operations; Highest First Quarter Non-GAAP Adjusted Free Cash Flow Since 2018 Record …
SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, …
Howard Hughes Holdings Inc. Strong start to the year affirms expectations for record MPC and Operating Assets performance in 2025 THE WOODLANDS, Texas, May 07, 2025 (GLOBE NEWSWIRE) -- Howard Hughes Holdings Inc. (NYSE: HHH) (the “Company,” “HHH,” “Howard Hughes,” or “we”) today announced …
Solid execution with first quarter results exceeding high end of outlook range First quarter revenue of $183.1 million, up 5% year-over-year Subscription revenue of $116.3 million, an increase of 8% year-over-year, reflecting ongoing progress in initiatives to grow subscription business First quarter net income …